Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $4.3 million.

  • Angiodynamics' Non-Current Deferred Tax Liability fell 6.92% to $4.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.3 million, marking a year-over-year decrease of 6.92%. This contributed to the annual value of $4.1 million for FY2025, which is 1605.52% down from last year.
  • Per Angiodynamics' latest filing, its Non-Current Deferred Tax Liability stood at $4.3 million for Q4 2025, which was down 6.92% from $4.3 million recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Non-Current Deferred Tax Liability peaked at $22.4 million during Q1 2021, and registered a low of $1.3 million during Q3 2023.
  • For the 5-year period, Angiodynamics' Non-Current Deferred Tax Liability averaged around $11.2 million, with its median value being $13.2 million (2023).
  • In the last 5 years, Angiodynamics' Non-Current Deferred Tax Liability crashed by 9153.82% in 2023 and then soared by 26168.88% in 2024.
  • Over the past 5 years, Angiodynamics' Non-Current Deferred Tax Liability (Quarter) stood at $18.0 million in 2021, then dropped by 20.58% to $14.3 million in 2022, then grew by 24.27% to $17.8 million in 2023, then tumbled by 75.59% to $4.3 million in 2024, then decreased by 0.07% to $4.3 million in 2025.
  • Its last three reported values are $4.3 million in Q4 2025, $4.3 million for Q3 2025, and $4.1 million during Q2 2025.